C, D., F, A., Y, T., F, B., S, R., M, C., & N, A. (2021). Development of PET Radioligands Targeting COX-2 for Colorectal Cancer Staging, a Review of in vitro and Preclinical Imaging Studies. Frontiers in medicine, 8, 675209. https://doi.org/10.3389/fmed.2021.675209
Chicago Style (17th ed.) CitationC, Dagallier, Avry F, Touchefeu Y, Buron F, Routier S, Chérel M, and Arlicot N. "Development of PET Radioligands Targeting COX-2 for Colorectal Cancer Staging, a Review of in Vitro and Preclinical Imaging Studies." Frontiers in Medicine 8 (2021): 675209. https://doi.org/10.3389/fmed.2021.675209.
MLA (9th ed.) CitationC, Dagallier, et al. "Development of PET Radioligands Targeting COX-2 for Colorectal Cancer Staging, a Review of in Vitro and Preclinical Imaging Studies." Frontiers in Medicine, vol. 8, 2021, p. 675209, https://doi.org/10.3389/fmed.2021.675209.